Tempest Therapeutics (TPST) EBITDA Margin Growth (3y) (2018)
Tempest Therapeutics (TPST) EBITDA Margin Growth (3y) (2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | -2,649.00 |
| 10 | Tempest Therapeutics | 4.46 Mn | 3.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 950,327.00 |
| Jun 30, 2018 | 5.11 Mn |
| Mar 31, 2018 | 10.55 Mn |